Jiwu Chang

405 total citations
21 papers, 324 citations indexed

About

Jiwu Chang is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Jiwu Chang has authored 21 papers receiving a total of 324 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 7 papers in Pulmonary and Respiratory Medicine and 7 papers in Oncology. Recurrent topics in Jiwu Chang's work include Bladder and Urothelial Cancer Treatments (7 papers), Cancer, Lipids, and Metabolism (3 papers) and Urological Disorders and Treatments (3 papers). Jiwu Chang is often cited by papers focused on Bladder and Urothelial Cancer Treatments (7 papers), Cancer, Lipids, and Metabolism (3 papers) and Urological Disorders and Treatments (3 papers). Jiwu Chang collaborates with scholars based in China, United States and Türkiye. Jiwu Chang's co-authors include Changying Li, Hongjie Li, Ting Zhang, Jianmin Li, Lingling Liu, Hongjie Li, Shixin Wang, Jin Wang, Huili Wu and Kai Li and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Biochemical and Biophysical Research Communications and International Journal of Molecular Medicine.

In The Last Decade

Jiwu Chang

21 papers receiving 317 citations

Peers

Jiwu Chang

SURGE

PRM

ONCOL

Veronica Yao Australia

Pieter De Mulder Netherlands

Jürgen Beck Germany

Zhouliang Wu China

Sima Pazouki United Kingdom

Jinjin Feng China

Mierxiati Abudurexiti China

Kiyotaka Kawashima Japan

Moritz Maas Germany

Veronica Yao Australia

Jiwu Chang

152 ×1.1

83 ×0.7

SURGE

39 ×0.4

156 ×1.8

PRM

66 ×1.4

ONCOL

Citations per year, relative to Jiwu Chang Jiwu Chang (= 1×) peers Veronica Yao

Countries citing papers authored by Jiwu Chang

Since Specialization

Citations

This map shows the geographic impact of Jiwu Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiwu Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiwu Chang more than expected).

Fields of papers citing papers by Jiwu Chang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiwu Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiwu Chang. The network helps show where Jiwu Chang may publish in the future.

Co-authorship network of co-authors of Jiwu Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Jiwu Chang. A scholar is included among the top collaborators of Jiwu Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiwu Chang. Jiwu Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhu, Yan, Maoti Wei, Yuanjie Niu, et al.. (2019). Postoperative prognostic model for patients with clear cell renal cell carcinoma in a Chinese population. International Journal of Urology. 26(6). 624–629. 4 indexed citations

Liu, Min, et al.. (2017). New applications of the acridine orange fluorescence staining method: Screening for circulating tumor cells. Oncology Letters. 13(4). 2221–2229. 14 indexed citations

Li, Hui, et al.. (2017). [Clinicopathological features of primary seminal vesicle adenocarcinoma: A report of 4 cases and review of the literature].. PubMed. 23(7). 639–645. 2 indexed citations

Li, Jianmin, Changying Li, Hongjie Li, et al.. (2017). MicroRNA‑30a‑5p suppresses tumor cell proliferation of human renal cancer via the MTDH/PTEN/AKT pathway. International Journal of Molecular Medicine. 41(2). 1021–1029. 19 indexed citations

Li, Changying, Kai Li, Ting Zhang, et al.. (2015). ZFX is a Strong Predictor of Poor Prognosis in Renal Cell Carcinoma. Medical Science Monitor. 21. 3380–3385. 10 indexed citations

Li, Changying, Hongjie Li, Ting Zhang, et al.. (2014). Discovery of Apo-A1 as a potential bladder cancer biomarker by urine proteomics and analysis. Biochemical and Biophysical Research Communications. 446(4). 1047–1052. 59 indexed citations

Zhang, Ting, Jingyao Wang, Xiaofeng Zhai, et al.. (2014). MiR-124 retards bladder cancer growth by directly targeting CDK4. Acta Biochimica et Biophysica Sinica. 46(12). 1072–1079. 39 indexed citations

Wang, Haitao, et al.. (2013). Clinical characteristics and prognostic factors of prostate cancer with liver metastases. Tumor Biology. 35(1). 595–601. 30 indexed citations

Li, Changying, Hongjie Li, Ting Zhang, et al.. (2013). [Significance of apolipoprotein A1 as biomarker for early diagnosis and classification of bladder urothelial carcinoma].. PubMed. 31(4). 266–70. 4 indexed citations

10.

Wang, Aixiang, Jiwu Chang, Changying Li, Kun Liu, & Ying-Li Lin. (2012). <b><i>H-ras</i></b> Mutation Detection in Bladder Cancer by COLD-PCR Analysis and Direct Sequencing. Urologia Internationalis. 88(3). 350–357. 10 indexed citations

11.

Li, Changying, Matthew R. Buckwalter, Sreyashi Basu, et al.. (2012). Dendritic cells sequester antigenic epitopes for prolonged periods in the absence of antigen-encoding genetic information. Proceedings of the National Academy of Sciences. 109(43). 17543–17548. 10 indexed citations

12.

Chang, Jiwu, et al.. (2012). [Correlation of histological prostatitis with PSA, prostate volume, PSAD, IPSS, Qmax and PVR in BPH patients].. PubMed. 18(3). 208–11. 2 indexed citations

13.

Li, Changying, et al.. (2011). Bone marrow mesenchymal stem cells differentiate into urothelial cells and the implications for reconstructing urinary bladder mucosa. Cytotechnology. 63(5). 531–539. 39 indexed citations

14.

Li, Hongjie, Changying Li, Huili Wu, et al.. (2011). Identification of Apo-A1 as a biomarker for early diagnosis of bladder transitional cell carcinoma. Proteome Science. 9(1). 21–21. 62 indexed citations

15.

Chen, Jing, Changyi Quan, Jiwu Chang, et al.. (2011). [Undifferentiated prostate sarcoma with cartilage metaplasia: a case report and review of the literature].. PubMed. 17(10). 918–22. 1 indexed citations

16.

Zhang, Zongliang, et al.. (2008). Quantitative risk stratification and individual comprehensive therapy for invasive bladder cancers in China. International Urology and Nephrology. 41(3). 571–577. 2 indexed citations

17.

Chang, Jiwu, et al.. (2006). Mucin-producing urothelial-type adenocarcinoma of the prostate (a case report and review of the literature). Chinese Journal of Clinical Oncology. 3(5). 370–372. 5 indexed citations

18.

Wu, Changli, et al.. (2006). MDR1/P-glycoprotein overexpression in bladder transitional cell carcinoma and its correlation with expression of survivin and Fas. Chinese Journal of Clinical Oncology. 3(3). 191–195. 7 indexed citations

19.

Liu, Ranlu, Yong Xu, & Jiwu Chang. (2005). The expression and significance of KAI1 and Ki67 in bladder transitional cell carcinoma. Chinese Journal of Clinical Oncology. 2(6). 888–893. 2 indexed citations

20.

Chang, Jiwu, et al.. (2004). [Generation of specific cytotoxicity T lymphocytes induced by tumor-derived heat shock protein 90-peptide complexes in vitro].. PubMed. 84(20). 1701–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact